Inhibitor Therapeutics (INTI) Interest & Investment Income (2023 - 2026)
Inhibitor Therapeutics (INTI) reported Interest & Investment Income of $4,664 for Q2 2026, down 87.0% from $35,831 a year earlier and down 49.3% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Interest & Investment Income (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inhibitor Therapeutics' Interest & Investment Income came in at $62,651, down 71.8% year-over-year; for FY2025, it was $126,316, down 60.3% from FY2024.
- By year, Interest & Investment Income came in at $318,208 in FY2024 (-16.0%) and $378,844 in FY2023.
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income in data going back to Q1 2023.
- Year over year, Interest & Investment Income has now declined in each of the last nine quarters, with an average decline of 57.9% over the last eight quarters.
- Across the past five years, year-over-year decline in Interest & Investment Income ran from 0.0% in Q1 2024 to 87.0% in Q2 2026.
- Per Business Quant data, the three quarters before Q2 2026 came in at $9,207 (Q1 2026), $19,749 (Q4 2025) and $29,031 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 4,664.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,664.00 |
| Mar 31, 2026 | 9,207.00 |
| Dec 31, 2025 | 19,749.00 |
| Sep 30, 2025 | 29,031.00 |
| Jun 30, 2025 | 35,831.00 |
| Mar 31, 2025 | 41,705.00 |
| Dec 31, 2024 | 62,406.00 |
| Sep 30, 2024 | 82,239.00 |
| Jun 30, 2024 | 83,457.00 |
| Mar 31, 2024 | 90,106.00 |
| Dec 31, 2023 | 106,008.00 |
| Sep 30, 2023 | 94,768.00 |
| Jun 30, 2023 | 87,940.00 |
| Mar 31, 2023 | 90,128.00 |
API Access
Inhibitor Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();